title: Response.
authors.affiliation: Division of Cancer Epidemiology and Genetics/Biostatistics Branch (WFA, PSR) and Division of Cancer Prevention (MES), Department of Health and Human Services/National Institutes of Health/National Cancer Institute, Bethesda, MD; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (AP); Department of Genetics and Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC (CMP). wanderso@mail.nih.gov.
authors.forename: William F
authors.initials: WF
authors.lastname: Anderson
authors.affiliation: Division of Cancer Epidemiology and Genetics/Biostatistics Branch (WFA, PSR) and Division of Cancer Prevention (MES), Department of Health and Human Services/National Institutes of Health/National Cancer Institute, Bethesda, MD; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (AP); Department of Genetics and Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC (CMP).
authors.forename: Philip S
authors.initials: PS
authors.lastname: Rosenberg
authors.affiliation: Division of Cancer Epidemiology and Genetics/Biostatistics Branch (WFA, PSR) and Division of Cancer Prevention (MES), Department of Health and Human Services/National Institutes of Health/National Cancer Institute, Bethesda, MD; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (AP); Department of Genetics and Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC (CMP).
authors.forename: Aleix
authors.initials: A
authors.lastname: Prat
authors.affiliation: Division of Cancer Epidemiology and Genetics/Biostatistics Branch (WFA, PSR) and Division of Cancer Prevention (MES), Department of Health and Human Services/National Institutes of Health/National Cancer Institute, Bethesda, MD; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (AP); Department of Genetics and Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC (CMP).
authors.forename: Charles M
authors.initials: CM
authors.lastname: Perou
authors.affiliation: Division of Cancer Epidemiology and Genetics/Biostatistics Branch (WFA, PSR) and Division of Cancer Prevention (MES), Department of Health and Human Services/National Institutes of Health/National Cancer Institute, Bethesda, MD; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (AP); Department of Genetics and Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC (CMP).
authors.forename: Mark E
authors.initials: ME
authors.lastname: Sherman
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000145:classification* / Q000209:etiology*; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins